CSIMarket
 


Amgen Inc   (AMGN)
Other Ticker:  
 
    Sector  Healthcare    Industry Biotechnology & Drugs
   Industry Biotechnology & Drugs
   Sector  Healthcare
 

AMGN's Revenue Growth by Quarter and Year

Amgen Inc 's Revenue results by quarter and year




AMGN Revenue (in millions $) FY 2021 FY 2020 FY 2019 FY 2018
IV Quarter December - 25,424.00 23,362.00 6,230.00
III Quarter September - - - 5,904.00
II Quarter June - - - 6,059.00
I Quarter March 0.00 - - 5,554.00
FY   - 25,424.00 23,362.00 23,747.00



AMGN Revenue first quarter 2021 Y/Y Growth Comment
Amgen Inc in the first quarter recorded of $ 0.00 millions.

According to the results reported in the first quarter, Amgen Inc achieved the best Revenue growth in Biotechnology & Drugs industry. While Amgen Inc ' s Revenue no change of % ranks overall at the positon no. in the first quarter.




AMGN Revenue ( Y/Y Growth %) 2021
2020 2019 2018
IV Quarter December - 8.83 % 274.99 % 7.38 %
III Quarter September - - - 2.27 %
II Quarter June - - - 4.29 %
I Quarter March - - - 1.65 %
FY   - 8.83 % -1.62 % 3.93 %

Financial Statements
Amgen Inc 's first quarter 2021 Revenue $ 0.00 millions AMGN's Income Statement
Amgen Inc 's first quarter 2020 Revenue $ 0.00 millions Quarterly AMGN's Income Statement
New: More AMGN's historic Revenue Growth >>


AMGN Revenue (Quarter on Quarter Growth %)

2021
2020 2019 2018
IV Quarter December - - - 5.52 %
III Quarter September - - - -2.56 %
II Quarter June - - - 9.09 %
I Quarter March - - - -4.27 %
FY (Year on Year)   - 8.83 % -1.62 % 3.93 %




Revenue first quarter 2021 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #

Revenue Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
Revenue first quarter 2021 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #
Revenue Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

Revenue by Quarter for the Fiscal Years 2018, 2019, 2020, 2021

Amgen Inc 's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


AMGN's I. Quarter Q/Q Revenue Comment
Current results of 0.00 millions by Amgen Inc come out even less good considering the 25,424.00 millions in the forth quarter.

Within Biotechnology & Drugs industry Amgen Inc achieved highest sequential Revenue growth. While Amgen Inc 's Revenue growth quarter on quarter, overall rank is .


Revenue Q/Q Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #
Revenue Q/Q Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #
Revenue Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


AMGN's I. Quarter Q/Q Revenue Comment
Recent of 0.00 millions by Amgen Inc appear even more unfavourable compare to the 25,424.00 millions a quarter before.

Within Biotechnology & Drugs industry Amgen Inc achieved highest sequential Revenue growth. While Amgen Inc 's Revenue growth quarter on quarter, overall rank is .


Amgen Inc 's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Mar 31 2021)
12 Months Ending
(Dec 31 2020)
12 Months Ending
(Sep 30 2020)
12 Months Ending
(Jun 30 2020)
12 Months Ending
(Mar 31 2020)
Cumulative Revenue 12 Months Ending $ 0.00 $ 0.00 $ 0.00 $ 0.00 $ 0.00
Y / Y Revenue Growth (TTM) - - - - -
Year on Year Revenue Growth Overall Ranking # # # # #
Seqeuential Revenue Change (TTM) - - - - -
Seq. Revenue Growth (TTM) Overall Ranking # # # # #




Cumulative Revenue growth Comment
In the Mar 31 2021 period, Amgen Inc 's cumulative trailing twelve month Revenue remained unchanged compare to the same period a year ago.

Amgen Inc achieved highest trailing twelve month year on year Revenue growth. While overall Revenue growth ranking, remained unchanged compare to the previous quarter at no. .

Revenue TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #

Revenue TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative Revenue growth Comment
In the Mar 31 2021 period, Amgen Inc 's cumulative trailing twelve month Revenue remained unchanged compare to the same period a year ago.

Amgen Inc achieved highest trailing twelve month year on year Revenue growth. While overall Revenue growth ranking, remained unchanged compare to the previous quarter at no. .

Revenue TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #

Revenue TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #




Other Revenue Growth
Biotechnology & Drugs Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
AMGN's Revenue Growth Ratio versus Biotechnology & Drugs Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth
Revenue Growth for AMGN's Competitors
Revenue Growth for Amgen Inc 's Suppliers
Revenue Growth for AMGN's Customers

You may also want to know
AMGN's Annual Growth Rates AMGN's Profitability Ratios AMGN's Asset Turnover Ratio AMGN's Dividend Growth
AMGN's Roe AMGN's Valuation Ratios AMGN's Financial Strength Ratios AMGN's Dividend Payout Ratio
AMGN's Roa AMGN's Inventory Turnover Ratio AMGN's Growth Rates AMGN's Dividend Comparisons



Companies with similar Revenue no change for the quarter ending Mar 31 2021 within Healthcare SectorY/Y Change %Revenue for the quarter ending Mar 31 2021
Community Health Systems Inc -0.40%$ -0.397 millions
Davita Inc -0.75%$ -0.747 millions
Neurometrix Inc -0.76%$ -0.763 millions
Inogen Inc -1.76%$ -1.760 millions
Tactile Systems Technology Inc -2.07%$ -2.068 millions
Mimedx Group Inc -2.87%$ -2.865 millions
Biomarin Pharmaceutical Inc-3.19%$ -3.195 millions
Lifevantage Corp-8.04%$ -8.037 millions
Amarin Corp Plcuk-8.27%$ -8.273 millions
Teva Pharmaceutical Industries Ltd-8.61%$ -8.607 millions
Healthcare Services Group Inc -9.22%$ -9.217 millions
Msa Safety Inc-9.59%$ -9.590 millions
Arvinas Inc -11.22%$ -11.223 millions
Mallinckrodt Plc-16.19%$ -16.191 millions
Biogen Inc -23.78%$ -23.776 millions
Anaptysbio inc-25.02%$ -25.020 millions
Acadia Healthcare Company Inc -26.73%$ -26.735 millions
Concert Pharmaceuticals Inc -28.57%$ -28.571 millions
Seres Therapeutics Inc -30.17%$ -30.175 millions
Sage Therapeutics Inc -30.75%$ -30.752 millions
Magellan Health inc -35.26%$ -35.259 millions
Glycomimetics Inc -88.27%$ -88.273 millions
Cyclerion Therapeutics Inc -93.89%$ -93.886 millions
Surface Oncology Inc -95.79%$ -95.787 millions


Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

ASPN's Profile

Stock Price

ASPN's Financials

Business Description

Fundamentals

Charts & Quotes

ASPN's News

Suppliers

ASPN's Competitors

Customers & Markets

Economic Indicators

ASPN's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2021 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071